Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 7/20 | 1.00 |
| ▸ | CA1 | P00915 | 5/20 | 1.00 |
| ▸ | CA12 | O43570 | 5/20 | 1.00 |
| ▸ | CA9 | Q16790 | 5/20 | 1.00 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 1.00 |
| ▸ | CA3 | P07451 | 3/20 | 1.00 |
| ▸ | CA4 | P22748 | 3/20 | 1.00 |
| ▸ | CA6 | P23280 | 3/20 | 1.00 |
| ▸ | CA5A | P35218 | 3/20 | 1.00 |
| ▸ | CA7 | P43166 | 3/20 | 1.00 |
| ▸ | CA13 | Q8N1Q1 | 3/20 | 1.00 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 1.00 |
| ▸ | MMP2 | P08253 | 2/20 | 0.66 |
| ▸ | MMP1 | P03956 | 1/20 | 0.66 |
| ▸ | MMP9 | P14780 | 1/20 | 0.66 |
| ▸ | MMP8 | P22894 | 1/20 | 0.66 |
| ▸ | MMP13 | P45452 | 1/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL620004 | 0.89 | CA2 (0.80) | CA2CA1CA12CA9CA14 | |
| SCHEMBL29631718 | 0.86 | CA2 (0.76) | CA2CA1CA12CA9CA14 | |
| SCHEMBL10494215 | 0.83 | CA2 (0.70) | CA2CA1CA12CA9CA14 | |
| SCHEMBL7629070 | 0.82 | SMN1; SMN2 (0.80) | CA2CA1CA12CA9CA14 | |
| SCHEMBL12517868 | 0.82 | CA2 (0.69) | CA2CA1CA12CA9CA14 | |
| SCHEMBL23703081 | 0.80 | CA2 (0.67) | CA2CA1CA12CA9CA14 | |
| SCHEMBL922350 | 0.80 | CA2 (0.71) | CA2CA1CA12CA9CA14 | |
| SCHEMBL6308870 | 0.79 | CA2 (0.66) | CA2CA1CA12CA9CA14 | |
| SCHEMBL10531768 | 0.79 | CA2 (0.66) | CA2CA1CA12CA9CA14 | |
| SCHEMBL12353364 | 0.79 | CA2 (0.66) | CA2CA1CA12CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117800852-A | Synthetic method of natural product salt spike grass alkali | 江西师范大学 | 2024-04-02 | — | — | CN | claimed |
| CN-115012007-A | Copper-graphene electroplating solution, copper-graphene composite foil and preparation method thereof | 江西理工大学 | 2022-09-06 | — | — | CN | claimed |
| CN-108117499-B | Preparation method of alpha aryl amidine imine derivative | 上海应用技术大学 | 2020-10-09 | — | — | CN | claimed |
| CN-108117499-A | A kind of preparation method of α aryl amidine imine derivative | 上海应用技术大学 | 2018-06-05 | — | — | CN | claimed |
| WO-2026106912-A1 | RAS INHIBITORS | Revolution Medicines, Inc. (US) | 2026-05-21 | — | — | WO | disclosed |
| EP-4719413-A1 | INHIBITORS OF CANINE JANUS KINASE AND USES THEREOF | Animol Discovery, Inc. (US) | 2026-04-08 | — | — | EP | disclosed |
| US-20260092070-A1 | INHIBITORS OF CANINE JANUS KINASE AND USES THEREOF | ANIMOL DISCOVERY INC (US) | 2026-04-02 | — | — | US | disclosed |
| EP-4563571-A1 | PRMT5 INHIBITORS | Beijing Earthwise Technology Co., Ltd. (CN) | 2025-06-04 | — | — | EP | disclosed |
| US-12275720-B2 | Small molecule inhibitors of galectin-3 | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-04-15 | — | — | US | disclosed |
| CN-119731154-A | PRMT5 inhibitors | 北京望实智慧科技有限公司 | 2025-03-28 | — | — | CN | disclosed |
| WO-2024246837-A1 | INHIBITORS OF CANINE JANUS KINASE AND USES THEREOF | ANIMOL DISCOVERY, INC. (US) | 2024-12-05 | — | — | WO | disclosed |
| US-20240366518-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF | LIFE EDIT THERAPEUTICS, INC. | 2024-11-07 | — | — | US | disclosed |
| CN-1276789-A | 4-aminothiazole derivatives, their preparation and their use as inhibitors of cyclin dependent kinases | AGOURON PHARMA (US) | 2000-12-13 | — | — | CN | disclosed |
| EP-1056732-A2 | 4-AMINOTHIAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF CYCLIN-DEPENDENT KINASES | AGOURON PHARMACEUTICALS, INC. (US) | 2000-12-06 | — | — | EP | disclosed |
| US-5932598-A | NOVEL SUBSTITUTED SULFONAMIDE COMPOUNDS USEFUL AS PRODRUGS; ADMINISTERING TO TREAT INFLAMMATION-ASSOCIATED PAIN DUE TO CANCER, DENTAL PAIN; CYCLOOXYGENASE-2 INHIBITORS | G. D. SEARLE & CO. (US) | 1999-08-03 | — | — | US | disclosed |
| WO-1999032466-A1 | SUBSTITUTED BENZENESULFONAMIDE DERIVATIVES AND THEIR PHARMACEUTICAL USE | NOVARTIS AG (CH) | 1999-07-01 | — | — | WO | disclosed |
| WO-1999021845-A2 | 4-AMINOTHIAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF CYCLIN-DEPENDENT KINASES | AGOURON PHARMACEUTICALS, INC. (US) | 1999-05-06 | — | — | WO | disclosed |
| EP-0892791-A1 | SUBSTITUTED BENZENESULFONAMIDE DERIVATIVES AS PRODRUGS OF COX-2 INHIBITORS | G.D. SEARLE & CO. (US) | 1999-01-27 | — | — | EP | disclosed |
| WO-1997038986-A1 | SUBSTITUTED BENZENESULFONAMIDE DERIVATIVES AS PRODRUGS OF COX-2 INHIBITORS | G.D. SEARLE & CO. (US) | 1997-10-23 | — | — | WO | disclosed |
| CN-1160400-A | Pyrrolyl tetrahydrobenzoquinoxalinediones, their preparation and their use as glutamate receptor antagonists | BASF AG (DE) | 1997-09-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12275720-B2 | Small molecule inhibitors of galectin-3 | LGALS3, LGALS3BP, LGALS1 | CA2 656/4885CA1 795/4885CA12 170/4885 |
| US-20240366518-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF | POLRMT, POLN, NSUN2 | CA2 4801/4885CA1 4733/4885CA12 3873/4885 |
| US-20260092070-A1 | INHIBITORS OF CANINE JANUS KINASE AND USES THEREOF | JAK1, JAK3, JAK2 | CA2 1072/4885CA1 2926/4885CA12 4095/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.